4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001695028-26-000004
Chief Financial Officer sold 52,000 shares at $13.51 ($702,686)
- Chief Financial Officer acquired 52,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic Chief Financial Officer | 2026-02-24 | Option exercise 10b5-1 | +52,000 | $4.36 | $226,720 | 120,148 | D |
| Piscitelli Dominic Chief Financial Officer | 2026-02-24 | Sale 10b5-1 | −52,000 | $13.51 | $702,686 | 68,148 | D |
| Derivatives | |||||||
| Piscitelli Dominic Chief Financial Officer | 2026-02-24 | Option exercise · Stock Option (right to buy) 10b5-1 | −52,000 | 144,500 | D | ||
| Open-market sales · 52,000 sh · avg $13.51 · $702,686 | |||||||
Loading xslF345X05/form4-02262026_090218.xml…